Hims & Hers Health Inc
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound ...
Hims & Hers shares plunge 28% on concerns over weight loss business
Shares of Hims & Hers Health closed down 22% on Tuesday, a day after the telehealth company released fourth-quarter results ...
FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running ...
Digital health stocks pummeled by Wall Street in 2024, but Hims surges
Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE If the Covid era marked ...
Weight-loss drug boom has become one of the internet’s biggest scams
A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A/S pharmaceutical manufacturing facility in ...
Amazon launches fixed pricing to treat hair loss, erectile dysfunction
A worker delivers Amazon packages in San Francisco on Oct. 24, 2024. David Paul Morris | Bloomberg | Getty Images ...
Digital health companies are launching programs around GLP-1s
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and ...
